Table of contents

Research Article

• The ursodeoxycholic acid story in primary biliary cirrhosis. (1 September, 1995)

  A G Lim, R P Jazrawi, T C Northfield
• Heartburn in patients with achalasia. (1 September, 1995)

  S J Spechler, R F Souza, S J Rosenberg, R A Ruben, R K Goyal
• Memory metal stents for palliation of malignant obstruction of the oesophagus and cardia. (1 September, 1995)

  A May, M Selmaier, J Hochberger, L Gossner, S Mühldorfer, E G Hahn, C Ell
• Helicobacter pylori and upper gastrointestinal disease: a survey of gastroenterologists in the United Kingdom. (1 September, 1995)

  R Milne, R P Logan, D Harwood, J J Misiewicz, D Forman
• Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects. (1 September, 1995)

  S Khulusi, M A Mendall, P Patel, J Levy, S Badve, T C Northfield
• Low dose famotidine and cimetidine in single postprandial doses: a placebo controlled comparative study of overnight pH. (1 September, 1995)

  T G Reilly, S G Mann, M Z Panos, R P Walt
• Effect of drink temperature on antropyloroduodenal motility and gastric electrical activity in humans. (1 September, 1995)

  W M Sun, R Penagini, G Hebbard, C Malbert, K L Jones, S Emery, J Dent, M Horowitz
• Epidermal growth factor in saliva and gastric juice: response to histamine. (1 September, 1995)

  A M Tunio, M Hobsley
• Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins. (1 September, 1995)

  F H Mourad, L J O'Donnell, J A Dias, E Ogutu, E A Andre, J L Turvill, M J Farthing
• Diagnostic and therapeutic push type enteroscopy in clinical use. (1 September, 1995)

  G R Davies, M J Benson, D J Gertner, R M Van Someren, D S Rampton, C P Swain
• Reversible effect of phytohaemagglutinin on the growth and metabolism of rat gastrointestinal tract. (1 September, 1995)

  S Bardocz, G Grant, S W Ewen, T J Duguid, D S Brown, K Englyst, A Pusztai
• Effect of intestinal resection on serum antibodies to the mycobacterial 45/48 kilodalton doublet antigen in Crohn's disease. (1 September, 1995)

  G Kreuzpaintner, P K Das, A Stronkhorst, A W Slob, G Strohmeyer
• Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells. (1 September, 1995)

  J Rugtveit, G Haraldsen, A K Høgåsen, A Bakka, P Brandtzaeg, H Scott
• Leucocyte-endothelial cell adhesion in a model of intestinal inflammation. (1 September, 1995)

  H Arndt, K D Palitzsch, D C Anderson, J Rusche, M B Grisham, D N Granger
• Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis. (1 September, 1995)

  I Lilja, K Smedh, G Olaison, R Sjödahl, C Tagesson, C Gustafson-Svärd
• A stable nitroxide radical effectively decreases mucosal damage in experimental colitis. (1 September, 1995)

  F Karmeli, R Eliakim, E Okon, A Samuni, D Rachmilewitz
• Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. (1 September, 1995)

  J Bohr, C Tysk, S Eriksson, G Järnerot
• Flow cytometric analysis of DNA synthetic phase fraction of the normal appearing colonic mucosa in patients with colorectal neoplasms. (1 September, 1995)

  S Nakamura, J Goto, Y Kitayama, J P Sheffield, I C Talbot
• C reactive protein and prealbumin as markers of disease activity in shigellosis. (1 September, 1995)

  W A Khan, M A Salam, M L Bennish
• Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. (1 September, 1995)

  L Muratori, M Lenzi, Y Ma, M Cataleta, G Mieli-Vergani, D Vergani, F B Bianchi
• Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolism. (1 September, 1995)

  A S Brown, J R Fiaterone, C P Day, M K Bennett, P J Kelly, O F James
• Inhibition of methanogenesis by human bile. (1 September, 1995)

  T H Florin, H J Woods
• Biliary aminopeptidase-N and the cholesterol crystallisation defect in cholelithiasis. (1 September, 1995)

  L Núñez, L Amigo, G Mingrone, A Rigotti, L Puglielli, A Raddatz, F Pimentel, A V Greco, S González, J Garrido
• Biochemical and morphological changes that characterise recovery from necrotising biliary pancreatitis in the opossum. (1 September, 1995)

  M Rünzi, A Saluja, A Kaiser, D Gerdes, A Sengupta, M L Steer
• Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis. (1 September, 1995)

  H Weidenbach, M M Lerch, T M Gress, D Pfaff, S Turi, G Adler
• A possible role for antibodies to tumour necrosis factor alpha and to endotoxin in the treatment of Reye's syndrome. (1 September, 1995)

  M Odeh